Hookipa pharma inc. (HOOK)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Operating activities:
Net loss

-10,926

-10,244

-11,385

-12,079

-9,329

-1,892

-3,953

-5,819

-4,573

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense

2,094

2,104

1,872

1,206

383

250

206

205

206

Depreciation expense

409

-771

766

1,108

297

138

171

151

140

Non-cash operating lease expense

494

-

-

-

269

-

-

-

-

Other non-cash items

-44

-1

0

3

-54

-8

6

-12

7

Changes in operating assets and liabilities:
Accounts receivable

1,292

5,118

393

1,617

-3,509

4,378

464

148

1

Prepaid expenses and other current assets

361

1,566

-1,136

1,864

3,711

3,465

1,232

1,463

889

Other non-current assets

-45

-287

-6,752

5,978

192

1,450

0

14

1

Accounts payable

2,644

2,558

651

1,952

-958

3,860

-861

1,036

-622

Deferred revenues

3,020

-1,077

-1,100

-1,330

-935

-51

-1,305

9,943

0

Operating lease liabilities

-428

-

-

-

-1,227

-

-

-

-

Accrued expenses and other liabilities

-2,871

5,762

-4,202

2,668

-216

564

277

872

-483

Net cash used in operating activities

-7,128

-8,793

-9,485

-11,397

-12,056

-6,376

-7,167

3,517

-4,972

Investing activities:
Purchases of property and equipment

199

1,046

362

191

400

250

280

1,358

262

Net cash used in investing activities

-199

-1,046

-362

-191

-400

-250

-280

-1,358

-262

Financing activities:
Payments related to finance leases

36

54

-23

11

1,395

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs

-

0

0

0

37,274

0

0

0

6,439

Proceeds from issuance of common stock, net of issuance costs

8

-

-

-

-

-

-

-

-

Payments for deferred offering costs

-

-

-

-

722

-

-

-

-

Proceeds from borrowings

-

-

-

-

-

-3

-5

-7

440

Repayments of borrowings

1,300

-

-

-

0

-

-

-

-

Net cash provided by financing activities

-1,284

-883

-532

76,009

35,157

6

-5

-7

6,879

Net increase (decrease) in cash, cash equivalents and restricted cash

-8,611

-10,722

-10,379

64,421

22,701

-

-

-

-

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-87

287

-824

284

-773

-

-

-

-

Supplemental disclosure of cash flow information:
Cash paid for interest

2

-

-

-

-

-

-

-

-

Net decrease / increase in cash and cash equivalents

-

-

-

-

-

-

-

-

1,645

Effect of exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

-

-

1,750

Cash paid for income taxes

0

-

9

100

0

-2

1

26

-1

Supplemental disclosure of non-cash investing activities:
Property and equipment additions in accounts payable and accrued expenses

539

-

-

-

153

-

-

-

-